Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: J Immunol. 2019 May 10;203(1):282–292. doi: 10.4049/jimmunol.1801068

Figure 2. SCFAs and CT promote OVA-specific antibody responses synergistically.

Figure 2.

Four groups (n= 4–5) of WT mice were orally immunized with 100 μg OVA alone, or together with 10 μg CT on day 0 and day 14 by gavage, and fed with or without the mixture of acetate and butyrate in drinking water for 28 days. Feces and serum samples were collected on days 14 and 28. (A-B) OVA-specific antibody levels in feces (A) and serum (B) were measured by ELISA. One representative of two independent experiments was shown. The data were expressed as mean ± s.e.m. *p < 0.05, **p < 0.01, ***p < 0.001.